Design Therapeutics, Inc. DSGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $656.19M.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s market capitalization?
- Design Therapeutics, Inc. (DSGN) reported market capitalization of $656.19M in Q1 2026.
- How has Design Therapeutics, Inc.'s market capitalization changed year-over-year?
- Design Therapeutics, Inc.'s market capitalization increased by 199.5% year-over-year, from $219.1M to $656.19M.
- What is the long-term trend for Design Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s market capitalization has grown at a -18.1% compound annual growth rate (CAGR), from $1.19B to $534.32M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.